In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2)
✍ Scribed by R. Rochford; C. L. Miller; M. J. Cannon; K. M. Izumi; E. Kieff; R. Longnecker
- Book ID
- 106212173
- Publisher
- Springer Vienna
- Year
- 1997
- Tongue
- English
- Weight
- 162 KB
- Volume
- 142
- Category
- Article
- ISSN
- 1432-8798
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Epstein-Barr virus (EBV) is a ubiquitous virus with infections commonly resulting in a latency carrier state. Although the exact role of EBV in cancer pathogenesis remains not entirely clear, it is highly probable that it causes several lymphoid and epithelial malignancies, such as Hodg
## Abstract The latent membrane protein (LMP) 2A, one of the membrane‐spanning polypeptides encoded by the Epstein‐Barr virus (EBV), has been implicated in the maintenance of viral latency and appears to function in part by inhibiting B‐cell receptor (BCR) signaling through its ITAM motifs. It has